Kelly J. Conn

446 total citations
13 papers, 376 citations indexed

About

Kelly J. Conn is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Kelly J. Conn has authored 13 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Neurology and 5 papers in Physiology. Recurrent topics in Kelly J. Conn's work include Alzheimer's disease research and treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Kelly J. Conn is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Kelly J. Conn collaborates with scholars based in United States, Australia and United Kingdom. Kelly J. Conn's co-authors include Richard E. Fine, Patricia B. Eisenhauer, John M. Wells, M. David Ullman, Ann C. McKee, Wenwu Gao, Michael S. Lan, Celeste B. Rich, Donna E. Jensen and Joel Rosenbloom and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and Brain Research.

In The Last Decade

Kelly J. Conn

13 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly J. Conn United States	9	174	122	96	81	57	13	376
Katsuhiro Tsuchiya Japan	6	181 1.0×	108 0.9×	67 0.7×	47 0.6×	78 1.4×	16	367
Kelly McCastlain United States	7	182 1.0×	59 0.5×	55 0.6×	52 0.6×	46 0.8×	8	429
Nikola Sladojević United States	11	196 1.1×	43 0.4×	55 0.6×	75 0.9×	41 0.7×	18	560
Hien Chau Canada	11	322 1.9×	81 0.7×	79 0.8×	143 1.8×	87 1.5×	14	637
D G Walker Canada	9	149 0.9×	36 0.3×	146 1.5×	51 0.6×	66 1.2×	9	487
Dustin Shilling United States	11	177 1.0×	76 0.6×	191 2.0×	33 0.4×	89 1.6×	15	501
Katherine Myers United States	8	190 1.1×	132 1.1×	49 0.5×	47 0.6×	50 0.9×	14	446
Betty Hom United States	10	186 1.1×	66 0.5×	89 0.9×	21 0.3×	35 0.6×	14	392
Sarah S. Alousi United States	11	229 1.3×	115 0.9×	36 0.4×	20 0.2×	47 0.8×	13	355
Phillip K. West Australia	10	125 0.7×	83 0.7×	44 0.5×	43 0.5×	20 0.4×	12	398

Countries citing papers authored by Kelly J. Conn

Since Specialization

Citations

This map shows the geographic impact of Kelly J. Conn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly J. Conn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly J. Conn more than expected).

Fields of papers citing papers by Kelly J. Conn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly J. Conn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly J. Conn. The network helps show where Kelly J. Conn may publish in the future.

Co-authorship network of co-authors of Kelly J. Conn

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly J. Conn. A scholar is included among the top collaborators of Kelly J. Conn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly J. Conn. Kelly J. Conn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Conn, Kelly J., et al.. (2016). OBSESSIVE COMPULSIVE DISORDER AND RECTAL PROLAPSE. European Neuropsychopharmacology. 26(5). 888–888. 1 indexed citations

Fernandes, Susan M., Laurie N. Fishman, Gregory S. Sawicki, et al.. (2012). REFERRAL PATTERNS AND PERCEIVED BARRIERS TO ADULT CONGENITAL HEART DISEASE CARE: RESULTS OF A SURVEY OF U.S. PEDIATRIC CARDIOLOGISTS. Journal of the American College of Cardiology. 59(13). E772–E772. 1 indexed citations

Lynch, John, Patricia B. Eisenhauer, Kelly J. Conn, et al.. (2006). Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures. Journal of Neuroscience Research. 83(7). 1262–1270. 36 indexed citations

Carreras, Isabel, M. David Ullman, Patricia B. Eisenhauer, et al.. (2005). Upregulation of clusterin/apolipoprotein J in lactacystin‐treated SH‐SY5Y cells. Journal of Neuroscience Research. 79(4). 495–502. 8 indexed citations

Conn, Kelly J., Wenwu Gao, Ann C. McKee, et al.. (2004). Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Research. 1022(1-2). 164–172. 119 indexed citations

Eisenhauer, Patricia B., Mary Jacewicz, Kelly J. Conn, et al.. (2004). Escherichia coli Shiga toxin 1 and TNF-α induce cytokine release by human cerebral microvascular endothelial cells. Microbial Pathogenesis. 36(4). 189–196. 39 indexed citations

Eisenhauer, Patricia B., Kelly J. Conn, John Lynch, et al.. (2004). Insulin degrading enzyme is expressed in the human cerebrovascular endothelium and in cultured human cerebrovascular endothelial cells. Neuroscience Letters. 371(1). 6–11. 22 indexed citations

Conn, Kelly J., et al.. (2003). cDNA Microarray Analysis of Changes in Gene Expression Associated with MPP+ Toxicity in SH-SY5Y Cells. Neurochemical Research. 28(12). 1873–1881. 15 indexed citations

Conn, Kelly J., Wenwu Gao, M. David Ullman, et al.. (2002). Specific up‐regulation of GADD153/CHOP in 1‐methyl‐4‐phenyl‐pyridinium‐treated SH‐SY5Y cells. Journal of Neuroscience Research. 68(6). 755–760. 29 indexed citations

10.

Conn, Kelly J., M. David Ullman, Patricia B. Eisenhauer, Richard E. Fine, & John M. Wells. (2001). Decreased expression of the NADH:ubiquinone oxidoreductase (complex I) subunit 4 in 1-methyl-4-phenylpyridinium -treated human neuroblastoma SH-SY5Y cells. Neuroscience Letters. 306(3). 145–148. 18 indexed citations

11.

Conn, Kelly J., Michael Pietropaolo, Shyr‐Te Ju, & Carmela R. Abraham. (1996). Monoclonal Antibodies Against the Human Metalloprotease EC 3.4.24.15 Label Neurofibrillary Tangles in Alzheimer's Disease Brain. Journal of Neurochemistry. 66(5). 2011–2018. 13 indexed citations

12.

Conn, Kelly J., Celeste B. Rich, Donna E. Jensen, et al.. (1996). Insulin-like Growth Factor-I Regulates Transcription of the Elastin Gene through a Putative Retinoblastoma Control Element. Journal of Biological Chemistry. 271(46). 28853–28860. 70 indexed citations

13.

Conn, Kelly J., et al.. (1994). Identification of full length β-amyloid precursor protein in human neuronal and non-neuronal cell culture supernatant: a possible extracellular source for the generation of Aβ. Amyloid. 1(4). 232–239. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact